ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.59965
-0.13%
Brent Oil
81.745
-0.85%
Bitcoin
70,005.33
-0.18%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. AQSE
  6. Apollon Formularies plc (APOL)

  7. Apollon Formularies plc (APOL) Noticias

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AQSE:APOL
FechaHoraFuenteTítuloSímboloCompañía
03/05/202406:59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
01/05/202409:00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
20/02/202404:59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
02/01/202402:18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
05/12/202305:59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
21/11/202305:51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
29/09/202301:00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
19/09/202303:18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
03/08/202304:51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
02/08/202306:19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
24/07/202305:00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
30/06/202311:32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
11/04/202308:00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
21/03/202307:00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
15/03/202302:00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
12/01/202301:00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
30/12/202206:37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
02/12/202201:00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
30/09/202203:50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
13/09/202201:02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
02/08/202203:11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
26/07/202201:00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
30/06/202210:29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
30/06/202206:33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
17/06/202207:23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/202206:07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
02/03/202201:01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
09/02/202201:00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
03/02/202200:59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
27/01/202201:00UK RegulatoryApollon Formularies plc Chief Science Officer Appointed as Board DirectorAQSE:APOLApollon Formularies plc
 Showing the most relevant articles for your search:AQSE:APOL

Su Consulta Reciente

CCOM
OILBRENT
Brent Oil
USI
USTECH100
US Tech 100
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
FX
USDMXN
US Dollar vs MXN
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
NYSE
XOM
Exxon Mobil
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados